Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.13
-0.62 (-2.08%)
Feb 21, 2025, 4:00 PM EST - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 197 employees as of December 31, 2023. The number of employees decreased by 10 or -4.83% compared to the previous year.
Employees
197
Change (1Y)
-10
Growth (1Y)
-4.83%
Revenue / Employee
$3,041,853
Profits / Employee
$449,716
Market Cap
939.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
COLL News
- 9 days ago - Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire
- 6 weeks ago - Collegium Provides 2025 Financial Guidance and Business Update - GlobeNewsWire
- 3 months ago - Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha
- 3 months ago - Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - GlobeNewsWire
- 3 months ago - Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript - Seeking Alpha